May 19, 2004 (Boston) — Valacyclovir is equally as effective as ganciclovir in preventing cytomegalovirus (CMV) in renal transplantation, and it may be more cost-effective as well, researchers ...

NEW YORK (Reuters Health) - Therapy with valacyclovir (Valtrex, GlaxoSmithKline), started within three months of infection with either herpes simplex virus type 1 (HSV-1) or HSV type 2 (HSV-2), ...

August 24, 2010 — Exposure to acyclovir or valacyclovir in the first trimester of pregnancy is not associated with an increased risk for major birth defects, according to the results of a large, ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Valacyclovir can be beneficial for treating multiple episodes of keratitis or iritis in patients with ...

Per-protocol survival improved versus earlier cutoffs, with 35% alive beyond 30 months and 13% beyond 50 months after two ...

Review the side-effects of Valacyclovir as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. WASHINGTON — Findings from a randomized, double-blind, ...

Hematopoietic stem cell transplantation (SCT), being performed with an increasing frequency for a variety of both malignant and non-malignant conditions, is associated with the occurrence of many ...

Oral acyclovir has been demonstrated to prevent reactivation of herpes simplex virus (HSV) infections when administered prophylactically to autologous bone marrow transplant (BMT) recipients or ...

In January 2024, Virios Therapeutics, Inc. (NASDAQ:VIRI) announced alignment with the U.S. Food and Drug Administration (FDA) on the requirements for advancing IMC-2 (valacyclovir + celecoxib) as a ...

ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to treat ...

Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...